ELUCIDATION OF PATHWAYS OF 5-FLUOROURACIL METABOLISM IN XENOGRAFTS OF HUMAN COLORECTAL ADENOCARCINOMA

被引：53
|
作者：
HOUGHTON, JA
HOUGHTON, PJ
机构：
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1983年 / 19卷 / 06期
关键词：
D O I：
10.1016/0277-5379(83)90013-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：807 / 815
页数：9
相关论文
共 50 条
  • [41] METABOLISM OF 5-FLUOROURACIL IN VARIOUS HUMAN NORMAL AND TUMOR-TISSUES
    MAEHARA, Y
    NAGAYAMA, S
    OKAZAKI, H
    NAKAMURA, H
    SHIRASAKA, T
    FUJII, S
    [J]. GANN, 1981, 72 (06): : 824 - 827
  • [42] PDMAEMA/SILK SERICIN HYBRID NANOCARRIERS FOR EFFICIENT DELIVERY OF 5-FLUOROURACIL AND OXALIPLATIN TO HUMAN COLORECTAL ADENOCARCINOMA TUMOUR CELLS
    Hudita, Ariana
    Stanciu, Diana Iuliana
    Serban, Mirela Violeta
    Galateanu, Bianca
    Radu, Ionut-cristian
    Tanas, Eugenia
    Zaharia, Catlin
    Burcea-dragomiroiu, George-traian-alexandru
    Marineci, Cristian-daniel
    Ginghina, Octav
    [J]. FARMACIA, 2024, 72 (04) : 805 - 815
  • [43] METABOLISM OF 5-FLUOROURACIL IN CULTURED-CELLS - PROTECTION FROM 5-FLUOROURACIL CYTOTOXICITY BY PURINES
    ULLMAN, B
    KIRSCH, J
    [J]. MOLECULAR PHARMACOLOGY, 1979, 15 (02) : 357 - 366
  • [44] Clinical colorectal cancer: "Ode to 5-Fluorouracil"
    Chu, Edward
    [J]. CLINICAL COLORECTAL CANCER, 2007, 6 (09) : 609 - 609
  • [45] FACTORS THAT INFLUENCE THE THERAPEUTIC ACTIVITY OF 5-FLUOROURACIL [6RS]LEUCOVORIN COMBINATIONS IN COLON ADENOCARCINOMA XENOGRAFTS
    HOUGHTON, JA
    WILLIAMS, LG
    LOFTIN, SK
    CHESHIRE, PJ
    MORTON, CL
    HOUGHTON, PJ
    DAYAN, A
    JOLIVET, J
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (06) : 423 - 432
  • [46] THE INFLUENCE OF METHOTREXATE (MTX) AND FOLINIC ACID (FA) ON 5-FLUOROURACIL (FU) KINETICS IN A PANEL OF HUMAN COLORECTAL CANCER (CRC) XENOGRAFTS INVIVO
    HERRMANN, R
    REUTER, J
    KRAAS, E
    KUNZ, W
    OSSWALD, H
    [J]. BLUT, 1988, 57 (04): : 201 - 201
  • [47] The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer
    Afzal, Shoaib
    Gusella, Milena
    Jensen, Soren Astrup
    Vainer, Ben
    Vogel, Ulla
    Andersen, Jon Traerup
    Brodbaek, Kasper
    Petersen, Morten
    Jimenez-Solem, Espen
    Adleff, Vilmos
    Budai, Barna
    Hitre, Erika
    Lang, Istvan
    Orosz, Eniko
    Bertolaso, Laura
    Barile, Carmen
    Padrini, Roberto
    Kralovanszky, Judit
    Pasini, Felice
    Poulsen, Henrik Enghusen
    [J]. PHARMACOGENOMICS, 2011, 12 (09) : 1257 - 1267
  • [48] Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance
    Nijhuis, Anke
    Thompson, Hannah
    Adam, Julie
    Parker, Alexandra
    Gammon, Luke
    Lewis, Amy
    Bundy, Jacob G.
    Soga, Tomoyoshi
    Jalaly, Aisha
    Propper, David
    Jeffery, Rosemary
    Suraweera, Nirosha
    McDonald, Sarah
    Thaha, Mohamed A.
    Feakins, Roger
    Lowe, Robert
    Bishop, Cleo L.
    Silver, Andrew
    [J]. HUMAN MOLECULAR GENETICS, 2017, 26 (08) : 1552 - 1564
  • [49] Effect of Boric Acid in Colorectal Adenocarcinoma Cell Line and Role on Chemotherapeutic Effect of 5-Fluorouracil
    Tureyen, Ali
    Gunay, Sevilay
    Erden, Yavuz
    Ince, Sinan
    [J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2021, 17 (01) : 57 - 64
  • [50] Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: A positron emission tomography study in rats
    Bading, JR
    Yoo, PB
    Fissekis, JD
    Alauddin, MM
    D'Argenio, DZ
    Conti, PS
    [J]. CANCER RESEARCH, 2003, 63 (13) : 3667 - 3674
12345